Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Fujifilm Invests US$83m to Expand Biotechnologies Microbial Capacity in UK

FUJIFILM Corporation plans to invest US$83 million dollars to expand microbial production capacity of FUJIFILM Diosynth Biotechnologies FDB

FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK

FUJIFILM Diosynth Biotechnologies FDBunveiled its plans for the construction of a new US$1905m 145m BioCampus at Billingham, UK

Thermo Fisher Opens New Commercial Manufacturing Site in Plainville, USA

Thermo Fisher Scientific Inc, has recently announced its plans to expand its facility for increasing capacity of viral vector development and manufacturing services located

Sanofi to Build a New World Class Research Centre

Sanofi plans to build a world class vaccine production site and a new research centre dedicated for the development of vaccines with an investment of 610 million

Evonik Expands Dossenheim and Hanau Sites in Germany

Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand for contract manufacturing

Klöckner Pentaplast Builds Klöckner Barrier Film (KBF) Facility

Klckner Pentaplast plans to expand its Klckner Barrier Film KBF facility, located in central Virginia in the United States Through this expansion, the company intendsto support the growing pharmaceuticals market

Berkshire Sterile Manufacturing to Expand Manufacturing Capabilities in Massachusetts

Berkshire Sterile Manufacturing BSM,has announced its expansion plans of adding new manufacturing capabilities

AGC Group to Establish New R&D Facility in Spain

AGC Inc plans to open a new R D facility to increase synthetic pharmaceutical production base in Spain The new R D facility is expected to start its operation in March 2021, while the expanded facility will come into existence

POINT Biopharma to Launch its First Manufacturing Facility in US

Canadabased clinicalstage biopharmaceutical company, POINT Biopharma POINT invests more than US$25 million to launch its first drug manufacturing facility in Indianapolis, US

FUJIFILM Diosynth Biotechnologies Starts North Carolina Facility Expansion

FUJIFILM Diosynth Biotechnologies has started the expansion of its North Carolina facility expansion project